PATENTLY ABSURD
AFTER all the laurels and accolades for developing a new-generation vaccine against COVID-19 at the height of the pandemic, the two competing companies that developed the mRNA jabs are facing off in a critical patent dispute. The outcome of the big-ticket litigation will determine how accessible the mRNA technology will be in developing future vaccines and therapies against a host of health hazards, ranging from influenza to cancer.
It took the industry by surprise when after a year of doing business peaceably and earning billions of dollars each, Moderna filed a patent infringement suit against its rival, PfizerBioNTech on August 26. BioNTech and Moderna had both developed their COVID-19 vaccines using the mRNA platform to attack the SARS-CoV-2 virus. While BioNTech, a biotechnology startup in Germany, tied up with multinational Pfizer for quick development of the Comirnaty vaccine, Moderna chose to go it alone to make its Spikevax vaccine.
Now, Moderna claims Pfizer-BioNTech has infringed three patents on its vaccine delivery system, which gets the drug inside a recipient's cells and generates a protein. In lawsuits filed in the US District Court for the District of Massachusetts and the Higher Regional Court of Düsseldorf, where BioNTech is based, Moderna says that Comirnaty infringes patents it had filed between 2010 and 2016 covering the company's "foundational mRNA technology". It accuses its competitor of copying "this groundbreaking technology" which was critical to the development of its own Spikevax.
هذه القصة مأخوذة من طبعة September 16, 2022 من Down To Earth.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 8500 مجلة وصحيفة.
بالفعل مشترك ? تسجيل الدخول
هذه القصة مأخوذة من طبعة September 16, 2022 من Down To Earth.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 8500 مجلة وصحيفة.
بالفعل مشترك? تسجيل الدخول
TURN OVER A NEW LEAF
The young leaves of pilkhan free are a worthy alternative to leafy vegetables in the spring season
The pill that's roiling US drug regulation
The hard right is challenging FDA's authority to regulate drugs with its lawsuit to ban America's most used abortion pill
FAIR PRICE
Using a calculator, Uttar Pradesh scientifically fixes fee for transporting faecal sludge to treatment plants
THE FOREVER POLLUTANT
From production to usage to disposal, plastic is a threat to those who come in its contact SIDDHARTH GHANSHYAM SINGH
Seeds from the past
For a decade,200 villages in Odisha have conserved and grown 190 indigenous rice and millet varieties with proven climate resilience
TESTING TIMES
While the world is trying to identify uniform tests to measure soil biodiversity, it still needs investment and infrastructure to make them available to all
BREAKING NEW GROUND
Soil health is typically measured by its nutrient content, by presence of elements like nitrogen and phosphorus. No country in the world measures it in terms of soil biodiversity-a counting of underground faunal populations and microorganisms.
PRIME TRIGGER
Heat stress dominates debate on the causes of a mysterious chronic kidney disease that continues to baffle health experts and is on the rise globally
Coral catastrophe
Consistent ocean heating puts global corals at risk of mass bleaching in 2024
CHIPKO A DISTANT MEMORY
Whenever a dictionary of green terms is written, no matter in what language, it will contain at least one Hindi word-Chipko, which means to hug.
